• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

聚集性脑细胞培养物中氟化3,4 - 二羟基苯丙氨酸异构体的比较代谢

Comparative metabolism of fluorinated 3,4-dihydroxyphenylalanine isomers in aggregating brain cell cultures.

作者信息

Wiese C, Cogoli-Greuter M, Weinreich R, Winterhalter K H

机构信息

Paul-Scherrer-Institut, Villigen-PSI, Zürich, Switzerland.

出版信息

J Neurochem. 1992 Jan;58(1):219-26. doi: 10.1111/j.1471-4159.1992.tb09299.x.

DOI:10.1111/j.1471-4159.1992.tb09299.x
PMID:1727432
Abstract

Fluorinated analogues of 3,4-dihydroxyphenylalanine (DOPA) were tested for intracellular metabolic conversion in aggregating cell cultures prepared from fetal rat brain. 5-Fluoro-D/L-DOPA was methylated almost exclusively to 3-O-methyl-5-fluoro-D/L-DOPA. Metabolism of 6-fluoro-D/L-DOPA resulted in 6-fluorodopamine, 6-fluoro-3,4-dihydroxyphenylacetic acid, and 3-O-methyl-6-fluoro-D/L-DOPA, but with a qualitatively and quantitatively different metabolite pattern compared with that of L-DOPA and D/L-DOPA, respectively. Homovanillic acid and fluorohomovanillic acid have not been found intracellularly in the cultures. On the basis of these data, the model development of the cerebral metabolism of tracers used in positron emission tomography can be improved.

摘要

在由胎鼠脑制备的聚集细胞培养物中,对3,4 - 二羟基苯丙氨酸(多巴)的氟化类似物进行了细胞内代谢转化测试。5 - 氟 - D/L - 多巴几乎完全甲基化为3 - O - 甲基 - 5 - 氟 - D/L - 多巴。6 - 氟 - D/L - 多巴的代谢产物包括6 - 氟多巴胺、6 - 氟 - 3,4 - 二羟基苯乙酸和3 - O - 甲基 - 6 - 氟 - D/L - 多巴,但与L - 多巴和D/L - 多巴的代谢产物模式相比,在定性和定量上均有所不同。在培养物的细胞内未发现高香草酸和氟高香草酸。基于这些数据,可以改进正电子发射断层扫描中使用的示踪剂的脑代谢模型开发。

相似文献

1
Comparative metabolism of fluorinated 3,4-dihydroxyphenylalanine isomers in aggregating brain cell cultures.聚集性脑细胞培养物中氟化3,4 - 二羟基苯丙氨酸异构体的比较代谢
J Neurochem. 1992 Jan;58(1):219-26. doi: 10.1111/j.1471-4159.1992.tb09299.x.
2
Metabolism of 5-fluoro-dopa and 6-fluoro-dopa enantiomers in aggregating cell cultures of fetal rat brain.5-氟多巴和6-氟多巴对映体在胎鼠脑聚集细胞培养物中的代谢
Biochem Pharmacol. 1992 Jul 7;44(1):99-105. doi: 10.1016/0006-2952(92)90043-i.
3
Cerebral metabolism of 6-[18F]fluoro-L-3,4-dihydroxyphenylalanine in the primate.灵长类动物大脑中6-[18F]氟-L-3,4-二羟基苯丙氨酸的代谢
J Neurochem. 1987 Apr;48(4):1077-82. doi: 10.1111/j.1471-4159.1987.tb05629.x.
4
COMT inhibitors and metabolism of fluorodopa enantiomers in aggregating cell cultures.儿茶酚-O-甲基转移酶抑制剂与聚集细胞培养物中氟多巴对映体的代谢
Naunyn Schmiedebergs Arch Pharmacol. 1993 Dec;348(6):582-5. doi: 10.1007/BF00167233.
5
Comparative in vivo metabolism of 6-[18F]fluoro-L-dopa and [3H]L-dopa in rats.大鼠体内6-[18F]氟-L-多巴和[3H]L-多巴的代谢比较
Biochem Pharmacol. 1990 Jun 15;39(12):1853-60. doi: 10.1016/0006-2952(90)90601-g.
6
Metabolites of 6-[18F]fluoro-L-dopa in human blood.
J Nucl Med. 1988 Mar;29(3):363-9.
7
Kinetics of in vitro decarboxylation and the in vivo metabolism of 2-18F- and 6-18F-fluorodopa in the hooded rat.带帽大鼠体内2-¹⁸F-和6-¹⁸F-氟多巴的体外脱羧动力学及体内代谢
Biochem Pharmacol. 1988 Jan 15;37(2):247-50. doi: 10.1016/0006-2952(88)90725-3.
8
The metabolism of [18F]6-fluoro-L-3,4-dihydroxyphenylalanine in the hooded rat.[18F]6-氟-L-3,4-二羟基苯丙氨酸在有头罩大鼠体内的代谢
J Neurochem. 1987 Feb;48(2):601-8. doi: 10.1111/j.1471-4159.1987.tb04135.x.
9
[18F]fluoro-L-dopa for the in vivo study of intracerebral dopamine.用于脑内多巴胺活体研究的[18F]氟-L-多巴
Int J Rad Appl Instrum A. 1986;37(8):669-75. doi: 10.1016/0883-2889(86)90260-1.
10
BIA 3-202, a novel catechol-O-methyltransferase inhibitor, enhances the availability of L-DOPA to the brain and reduces its O-methylation.BIA 3-202,一种新型儿茶酚-O-甲基转移酶抑制剂,可提高左旋多巴进入大脑的利用率并减少其O-甲基化。
Eur J Pharmacol. 2001 May 18;420(1):27-32. doi: 10.1016/s0014-2999(01)01020-2.

引用本文的文献

1
COMT inhibitors and metabolism of fluorodopa enantiomers in aggregating cell cultures.儿茶酚-O-甲基转移酶抑制剂与聚集细胞培养物中氟多巴对映体的代谢
Naunyn Schmiedebergs Arch Pharmacol. 1993 Dec;348(6):582-5. doi: 10.1007/BF00167233.